Toripalimab

ATC L01FF13 · 9 markets · 13 records

Toripalimab 9 markets · 13 records Forms

AU 3 records · 3 strengths

240 mg/6 mLinjectionZytorvi also in US·GB·SG
240 mginjectionZYTORVI toripalimab 240 mg/ 6 mL concentrated injection vial also in CN·ES unknown

Records without a stated strength · 1 Zytorvi

CN 3 records · 3 strengths

240 mginjection拓益特瑞普利单抗 also in AU·ES
100 mginjection拓益特瑞普利单抗
80 mginjection拓益特瑞普利单抗

US 1 records · 1 strengths

240 mg/6 mLinjectionLOQTORZI also in AU·GB·SG

GB 1 records · 1 strengths

240 mg/6 mLinjectionLoqtorzi 240mg/6ml concentrate for solution for infusion vials also in AU·US·SG

CA 1 records · 1 strengths

40 mgliquidLOQTORZI

SG 1 records · 1 strengths

240 mg/6 mLinjectionLOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML also in AU·US·GB

ES 1 records · 1 strengths

240 mginjectionLOQTORZI also in AU·CN

HK 1 records · 1 strengths

Records without a stated strength · 1 LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 LOQTORZI

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	HK	EU
240 mg/6 mL injection	LOQTORZI	Loqtorzi 240mg/6ml concentrate for solution for infusion vials	not recorded	Zytorvi	LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML	not recorded	not recorded	not recorded	not recorded
240 mg injection	not recorded	not recorded	not recorded	ZYTORVI toripalimab 240 mg/ 6 mL concentrated injection vial	not recorded	拓益特瑞普利单抗	LOQTORZI	not recorded	not recorded
40 mg liquid	not recorded	not recorded	LOQTORZI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	拓益特瑞普利单抗	not recorded	not recorded	not recorded
80 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	拓益特瑞普利单抗	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Zytorvi	not recorded	not recorded	not recorded	LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML	LOQTORZI

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.